CPRT COPART INC Insider Trading

CEO Jeffrey Liaw sells 26.2K shares of CPRT for $869.7K; stock down -47.6% from 52-week high, latest holdings at 79.5K.

Jeffrey Liaw, Chief Executive Officer of Copart Inc, executed two separate sales totaling 26,213 shares for $869,723.91 on 2026-04-15, reducing his holdings by approximately 24.8% to 79.5K shares post-transaction. The sale occurred at a blended average price of $33.18 against a current price of $33.45, representing execution near flat, but the stock has fallen -47.6% from its 52-week high of $63.84 and trades down -18.5% over the trailing 90 days. Liaw's prior trading history at Copart shows consistent downside capture: all 5 prior sales at this ticker posted negative 90-day returns, with 100% timing success rate at the 90-day mark; his cross-ticker track record reflects an avg 90d return of -9.7% and a 100.00% well-timed rate across 8 other open-market sells. The transaction is material in size and timing relative to recent price weakness and his demonstrated pattern of selling ahead of sustained declines.

CEO Jeffrey Liaw sold 25,137 shares of CPRT for $1.0M; maintains 56.0K shares post-transaction.

CEO Jeffrey Liaw executed two separate sales totaling 25,137 shares for $1,009,753.29 at $40.17 on 2026-01-15, reducing his holdings by 31.0% to 55,970 shares. His cross-ticker track record shows a 100.00% well-timed rate on sells (6 prior sales with avg 90d return -7.3%), and at CPRT specifically, 5 of 5 prior sells were well-timed at the 90-day mark, with most recent sells in October 2025 posting 90-day returns of -8.3% and -11.0%. The current stock price of $41.04 is +4.9% over 30 days but -7.4% over 90 days, and trading -35.7% from its 52-week high of $63.84. Fundamentals remain solid with $1.2B quarterly revenue, $403.7M net income, and 9.7% annual revenue growth, suggesting the sell reflects tactical position sizing rather than conviction concerns.

Director Thomas Tryforos sold entire 100,000-share CPRT position for $3.9M at $39.07; now holds zero shares after -38.8% drawdown from 52-week high.

Thomas Tryforos liquidated his entire 100,000-share stake in Copart on 2025-11-25, reducing his holdings from 100,000 shares to zero. The sale occurred at $39.07 per share, valuing the transaction at $3,907,000.00, and came after the stock had declined 38.8% from its 52-week high of $63.84. His prior four sales at Copart show a pattern of well-timed exits: three of three measurable 90-day outcomes were negative (stock fell after the sale), including a -50.6% decline following his May 2023 sale. This complete exit during a pronounced downtrend, combined with his demonstrated track record of selling before further declines at this specific ticker, marks a material change in insider positioning that warrants attention given the company's solid fundamentals (P/E 23.67, $403.7M net income, 9.7% annual revenue growth).

CEO Liaw Jeffrey sold 24,283 shares at $44.79–$44.80 for $1.1M, reducing holdings 43.7%; prior CPRT trades 100% well-timed at 90-day horizon.

Liaw Jeffrey, Chief Executive Officer of Copart, executed 2 separate sales totaling 24,283 shares for $1,087,668.11 at a blended average price of $44.79 on 2025-10-15. The sale reduces his holdings from 55,615 to 31,332 shares (a -43.7% reduction). Notably, all 4 of his prior trades at CPRT have been well-timed at the 90-day mark: each generated negative 90-day returns ranging from -4.9% to -6.0%, meaning the stock declined after each sale. The current price of $44.34 is -30.6% from the 52-week high of $63.84, and the stock has declined -4.9% over the past 30 days. Given his consistent track record of selling ahead of downturns at this ticker, this substantial reduction of his largest insider position warrants investor attention, particularly as the company's fundamentals remain solid (revenue $1.2B, net income $406.6M, P/E 25.78) but price momentum has turned negative.

Director Tryforos Thomas N exits entire 228,840 share CPRT position worth $10.9M at $47.54, marking complete divestment from Copart

Director Thomas N. Tryforos sold his complete 228.8K share holding in COPART INC on 2025-09-15 at $47.54, totaling $10.9M and reducing post-transaction holdings to zero. His cross-ticker track record shows strong timing discipline: 100.00% well-timed rate on his prior 3 sells with an average 90-day return of -22.3%, and at CPRT specifically, all 3 prior sells were well-timed at the 90-day mark with the most recent (2024-12-05) showing -12.0% at 90 days. The stock has since declined 1.6% in 30 days and sits -27.0% from its 52-week high of $63.84, with current price $46.62. A director's complete exit of a $10.9M position, combined with a documented pattern of well-timed exits at this specific ticker, warrants investor attention to the underlying factors influencing this full divestment.

Liaw (CEO) sells 24,088 shares at avg $46.43 for $1.1M; post-sale stake 31,527 shares (-43.3%)

CEO Jeffrey Liaw executed 4 separate sales on 2025-07-15 totaling 24,088 shares for $1,118,419.35, reducing his holdings from 55,615 to 31,527 shares—a reduction of 43.3% versus pre-transaction holdings. The blended average sale price of $46.43 sits 1.0% above the current price of $45.98, while the stock is down 5.0% over 30 days and 23.0% over 90 days from a 52-week high of $63.84. With the company posting quarterly revenue of $1,211,716,000 and net income of $406,609,000, this substantial reduction in CEO equity stake deserves attention given the stock's recent weakness and elevated valuation (P/E: 30.05), though the transaction details remain factual and do not by themselves indicate forward guidance.

Director COHAN STEVEN D sold 100,000 shares ($6.0M) in 2 transactions at $60.01, exiting position entirely

Steven D. Cohan, Director at COPART INC, executed 2 separate sales totaling 100,000 shares for $6,001,000.00 at $60.01 per share on 2025-04-11 and 2025-04-14, reducing his holdings from 100.0K shares to 0 shares post-transaction (-100.0%). The transaction price of $60.01 is near the current price of $60.45 and within the 52-week range ($49.19–$63.80), indicating execution near current market levels. Notably, Cohan's prior sell at CPRT on 2023-05-30 showed strong 90-day timing with a -50.5% return, placing it in the well-timed category (1 of 1 prior sells at this ticker met the 90-day benchmark). The complete liquidation of a director's full position is a material corporate governance signal, regardless of price-action context, and warrants attention given the company's fundamental backdrop (revenue $1.2B, net income $387.4M, P/E 40.03).

Director Meeks sells entire 100,000 share CPRT stake at $54.00, position now zero; stock down -10.2% in 30 days.

James E. Meeks, a director of Copart Inc, sold 100,000 shares on 2025-03-19 at $54.00 for a total of $5,400,000.00, eliminating his entire holdings in the company. This complete exit occurs as CPRT trades -15.9% from its 52-week high of $63.80, and the stock has declined -10.2% over the prior 30 days. Meeks' cross-ticker track record shows 1 prior sell with an average 90-day return of -51.4% and a 90-day well-timed rate of 100.00%, and his same-ticker history at CPRT shows a prior sell on 2023-05-22 that was well-timed (90-day return -51.4% post-sale). This transaction merits focus given the complete liquidation of a director's position in a $51.8B market-cap company combined with the insider's demonstrated pattern of exiting before further stock declines.

Director Daniel J Englander sells entire 320,000-share CPRT stake for $18.2M across 2 transactions

Daniel J Englander, a director at Copart, executed two separate sales totaling 320,000 shares for $18,210,775.20 on January 3 and 6, 2025, at a blended average price of $56.91—reducing his holdings from 320,000 shares to zero. This complete liquidation of his equity stake represents a material reduction in insider ownership. At the prior sale date (January 3, 2024), his cross-ticker track record showed a 90-day return of +21.7%, indicating his sells at this ticker have not historically preceded declines; the current stock price of $56.24 is 9.4% lower than 30 days prior and 11.8% below the 52-week high, positioning this liquidation near recent resistance levels. The timing of a total director exit—especially at a company with a $54.2B market cap generating $362.1M in net income last quarter—warrants investor attention regarding potential forward guidance changes or strategic reassessment.

Director Matt Blunt sold entire 50,000-share CPRT stake for $2.9M on Jan 2, now worth $2.8M at $56.58

Director Matt Blunt liquidated his complete 50,000-share position in COPART on 2025-01-02 at $57.66 per share for $2,883,000.00. The stock has since declined 8.9% over 30 days and now trades at $56.58, approximately 11.3% below its 52-week high of $63.80. Across his prior two sales at CPRT (on 2024-02-26 and 2023-10-03), neither proved well-timed at the 90-day mark, with subsequent returns of +12.1% and +5.0% respectively, indicating the stock generally moved upward after those exit points. This complete divestiture from a $54.5B market-cap company with recent quarterly net income of $362,086,000.00 and annual revenue growth of +9.5% removes his entire disclosed holding and represents a material shift in his ownership stake.